The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand

Asalaysa Bushyakanist1 Department of Medicine, Mahidol University, Bangkok, Thailand

Apichaya Puangpetch2 Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand;3 Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand

Chonlaphat Sukasem2 Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand;3 Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand

Sasisopin Kiertiburanakul1 Department of Medicine, Mahidol University, Bangkok, ThailandCorrespondence[email protected]

Pages 163-170 | Published online: 05 Nov 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

UNAIDSUNAIDS report on the Global AIDS epidemic 20132013Accessed March 4, 2015 Available from: http://www.unaids.org/en/resources/campaigns/20121120_globalreport2012/globalreport
Google Scholar
UNAIDSGlobal report 2012: AIDS info 20122012Accessed March 1, 2015 Available from: http://www.unaids.org/en/dataanalysis/datatools/aidsinfo
Google Scholar
UNAIDSGlobal AIDS response progress reporting 20122012Accessed March 1, 2015 Available from http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/document/2011/JC2215_Global_AIDS_Response_Progress_Reporting_en.pdf
Google Scholar
ShetAAntonyJArumugamKKumar DodderiSRodriguesRDeCostaAInfluence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in IndiaPLoS One20149e9102824614165
PubMed Web of Science ®Google Scholar
d’Arminio MonforteALepriACRezzaGInsights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive PatientsAIDS20001449950710780712
PubMed Web of Science ®Google Scholar
ChantratitaWKiertiburanakulSSungkanuparphSCharoenyingwattanaAMahasirimongkolSIntegrating HIV-1 pharmacogenomics into the universal coverage health-care system in Thailand: from scientific evidence to policyJ Pharmacogenomics Pharmacoproteomics2011S616
Google Scholar
TozziVPharmacogenetics of antiretroviralsAntiviral Res20108519020019744523
PubMed Web of Science ®Google Scholar
SukasemCCresseyTRPrapaithongPPharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adultsBr J Clin Pharmacol2012741005101222471906
PubMed Web of Science ®Google Scholar
ManosuthiWSukasemCLueangniyomkulAImpact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patientsAntimicrob Agents Chemother2013571019102423254426
PubMed Web of Science ®Google Scholar
SukasemCChamnanphonMKoomdeeNPharmacogenetics and clinical biomarkers for subtherapeutic plasma efavirenz concentration in HIV-1 infected Thai adultsDrug Metab Pharmacokinet20142928929524477223
PubMed Web of Science ®Google Scholar
CresseyTRLallemantMPharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an updateInfect Genet Evol2007733334217045554
PubMed Web of Science ®Google Scholar
ClarkeHMousaSAThe implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descentPharmgenomics Pers Med20092939923226038
PubMedGoogle Scholar
HaasDWPharmacogenomics and HIV therapeuticsJ Infect Dis20051911397140015809895
PubMed Web of Science ®Google Scholar
Department of Disease Control MoPHThailand National Guidelines on HIV/AIDS Treatment and Prevention 2014Thailand2014 Available from: http://www.thaiaidssociety.org/images/PDF/hiv_guideline_2557.pdfAccessed March 1, 2015
Google Scholar
WangsomboonsiriWMahasirimongkolSChantarangsuSAssociation between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimenClin Infect Dis20105059760420073992
PubMed Web of Science ®Google Scholar
AnanworanichJMoorZSiangphoeUIncidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugsAIDS20051918519215668544
PubMed Web of Science ®Google Scholar
ChantarangsuSMushirodaTMahasirimongkolSHLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patientsPharmacogenet Genomics20091913914619104471
PubMed Web of Science ®Google Scholar
MarzoliniCTelentiADecosterdLAGreubGBiollazJBuclinTEfavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patientsAIDS200115717511192870
PubMed Web of Science ®Google Scholar
KDIGOClinical practice guideline for acute kidney injury 20122012Accessed March 1, 2015 Available from: http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO%20AKI%20Guideline.pdf
Google Scholar
LongoDLFauciASKasperDLHauserSLJamesonJLLoscalzoJHarrison’s Principles of Internal Medicine18 edNew YorkMcGraw-Hill2012
Google Scholar
MallalSNolanDWittCAssociation between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavirLancet200235972773211888582
PubMed Web of Science ®Google Scholar
NolanDGaudieriSMallalSPharmacogenetics: a practical role in predicting antiretroviral drug toxicity?J HIV Ther20038364112838163
PubMedGoogle Scholar
PuthanakitTBunupuradahTKosalaraksaPPrevalence of human leukocyte antigen-B*5701 among HIV-infected children in Thailand and Cambodia: implications for abacavir usePediatr Infect Dis J20133225225322986704
PubMed Web of Science ®Google Scholar
PhillipsEJGenetic screening to prevent abacavir hypersensitivity reaction: are we there yet?Clin Infect Dis20064310310516758425
PubMed Web of Science ®Google Scholar
ParkWBChoePGSongKHShould HLA-B*5701 screening be performed in every ethnic group before starting abacavir?Clin Infect Dis20094836536719115972
PubMed Web of Science ®Google Scholar
MiddletonDMenchacaLRoodHKomerofskyRNew allele frequency database: http://www.allelefrequencies.netTissue Antigens20036140340712753660
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date